Patents by Inventor Hawkins V. Maulding

Hawkins V. Maulding has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Targeted therapeutics and uses thereof
    Patent number: 7122525
    Abstract: The invention features a method of delivering a drug to a diseased cell by linking the drug to a rifamycin derivative, compositions that include drug-rifamycin conjugates of the invention, and methods for treating disease using those compositions.
    Type: Grant
    Filed: November 21, 2002
    Date of Patent: October 17, 2006
    Assignee: ActivBiotics, Inc.
    Inventors: Arthur F. Michaelis, Hawkins V. Maulding, Chalom Sayada, Congxiang Zha
  • Sulfhydryl rifamycins and uses thereof
    Patent number: 7078399
    Abstract: The invention features sulfhydryl rifamycin compositions, methods of making these compositions, and methods for treating disease using these compositions.
    Type: Grant
    Filed: December 12, 2002
    Date of Patent: July 18, 2006
    Assignee: ActivBiotics, Inc.
    Inventors: Arthur F. Michaelis, Hawkins V. Maulding, Chalom Sayada, Barry Eisenstein, William B. Geiss, Joseph Raker
  • Antimicrobial agents and uses thereof
    Patent number: 6900204
    Abstract: The invention features compounds that act as antimicrobial agents and/or antimicrobial enhancer agents, compositions that include the antimicrobial enhancer agents of the invention, and methods for treating microbial infections using those compositions.
    Type: Grant
    Filed: September 6, 2002
    Date of Patent: May 31, 2005
    Assignee: ActivBiotics, Inc.
    Inventors: Arthur F. Michaelis, Hawkins V. Maulding
  • Targeted therapeutics and uses thereof
    Publication number: 20040063718
    Abstract: The invention features a method of delivering a drug to a diseased cell by linking the drug to a rifamycin derivative, compositions that include drug-rifamycin conjugates of the invention, and methods for treating disease using those compositions.
    Type: Application
    Filed: November 21, 2002
    Publication date: April 1, 2004
    Inventors: Arthur F. Michaelis, Hawkins V. Maulding, Chalom Sayada, Congxiang Zha
  • Sulfhydryl rifamycins and uses thereof
    Publication number: 20040014749
    Abstract: The invention features sulfhydryl rifamycin compositions, methods of making these compositions, and methods for treating disease using these compositions.
    Type: Application
    Filed: December 12, 2002
    Publication date: January 22, 2004
    Inventors: Arthur F. Michaelis, Hawkins V. Maulding, Chalom Sayada, Barry Eisenstein, William B. Geiss, Joseph Raker
  • Metal complexes and formulations of rifamycin analogues and uses thereof
    Publication number: 20040014750
    Abstract: The invention features compositions that include rifamycin analogues formulated with metal salts, metal complexes of rifamycin analogues, and methods for treating disease using these compositions.
    Type: Application
    Filed: December 12, 2002
    Publication date: January 22, 2004
    Inventors: Arthur F. Michaelis, Hawkins V. Maulding, Chalom Sayada, Barry Eisenstein
  • Antimicrobial agents and uses thereof
    Publication number: 20030105086
    Abstract: The invention features compounds that act as antimicrobial agents and/or antimicrobial enhancer agents, compositions that include the antimicrobial enhancer agents of the invention, and methods for treating microbial infections using those compositions.
    Type: Application
    Filed: September 6, 2002
    Publication date: June 5, 2003
    Inventors: Arthur F. Michaelis, Hawkins V. Maulding
  • Sustained release formulations of water soluble peptides
    Patent number: 5876761
    Abstract: The invention discloses microparticles comprising a polypeptide, preferably somatostatin or an analog or derivative thereof, more preferably octreotide, in a polymeric matrix, preferably poly(lactide-co-glycolide) glucose. The invention also discloses sustained release formulations containing said microparticles and the use of said formulations in treating acromegaly and breast cancer.
    Type: Grant
    Filed: June 6, 1995
    Date of Patent: March 2, 1999
    Assignee: Novartis AG
    Inventors: David Bodmer, Jones W. Fong, Thomas Kissel, Hawkins V. Maulding, Oskar Nagele, Jane E. Pearson
  • Sustained release formulations of water soluble peptides
    Patent number: 5688530
    Abstract: The invention discloses microparticles comprising a polypeptide, preferably somatostatin or an analog or derivative thereof, more preferably octreotide, in a polymeric matrix, preferably poly(lactide-co-glycolide) glucose. The invention also discloses sustained release formulations containing said microparticles and the use of said formulations in treating acromegaly and breast cancer.
    Type: Grant
    Filed: June 6, 1995
    Date of Patent: November 18, 1997
    Assignee: Novartis AG
    Inventors: David Bodmer, Jones W. Fong, Thomas Kissel, Hawkins V. Maulding, Oskar Nagele, Jane E. Pearson
  • Sustained release formulations of water soluble peptides
    Patent number: 5639480
    Abstract: The invention discloses microparticles comprising a polypeptide, preferably somatostatin or an analog or derivative thereof, more preferably octreotide, in a polymeric matrix, preferably poly(lactide-co-glycolide)glucose. The invention also discloses sustained release formulations containing said microparticles and the use of said formulations in treating acromegaly and breast cancer.
    Type: Grant
    Filed: June 6, 1995
    Date of Patent: June 17, 1997
    Assignee: Sandoz Ltd.
    Inventors: David Bodmer, Jones W. Fong, Thomas Kissel, Hawkins V. Maulding, Oskar Nagele, Jane E. Pearson
  • Sustained release formulations of water soluble peptides
    Patent number: 5538739
    Abstract: The invention discloses microparticles comprising a polypeptide, preferably somatostatin or an analog or derivative thereof, more preferably octreotide, in a polymeric matrix, preferably poly(lactide-co-glycolide) glucose. The invention also discloses sustained release formulations containing said microparticles and the use of said formulations in treating acromegaly and breast cancer.
    Type: Grant
    Filed: January 18, 1991
    Date of Patent: July 23, 1996
    Assignee: Sandoz Ltd.
    Inventors: David Bodmer, Jones W. Fong, Thomas Kissel, Hawkins V. Maulding, Jr., Oskar Nagele, Jane E. Pearson
  • Non-irritating injectable dosage forms
    Patent number: 4297353
    Abstract: A non-irritating injectable dosage form of a tissue irritating medicament, comprising the medicament and a pharmaceutically acceptable glyceride vehicle comprising a glycerol ester of a saturated or unsaturated fatty acid having from 6 to 20 carbon atoms or mixtures thereof.
    Type: Grant
    Filed: August 4, 1980
    Date of Patent: October 27, 1981
    Assignee: Sandoz, Inc.
    Inventor: Hawkins V. Maulding
  • Iontophoretic delivery of peptides
    Patent number: H1160
    Abstract: The invention concerns a new system and method for iontophoretically delivering a polypeptide transdermally into animal tissue.
    Type: Grant
    Filed: November 26, 1990
    Date of Patent: April 6, 1993
    Inventors: Hawkins V. Maulding, James R. Siverly